IKZF2 and glycogen storage disease VI: leadoptimization phasefor a cereblon molecular glue targeting IKZF2 for the treatment ofimmune disease and cancer; drug discovery phase for a disclosed novelE3 ligase molecular glue and also undisclosed partnered molecularglue programs129